LumiraDx SARS-CoV-2 Ag Technical Bulletin – QC Transfer Pipettes

The LumiraDx SARS-CoV-2 Ag Quality Controls (QC) are liquid quality controls used with the LumiraDx Instrument and the LumiraDx SARS-CoV-2 Ag Test. When transferring the QC material from the vial to the Test Strip, a transfer pipette is used.

Please be advised that the following transfer pipettes are acceptable for use with the LumiraDx SARS-CoV-2 Ag QC material:

Please note that any transfer pipettes used with the LumiraDx SARS-CoV-2 Ag QC material should never contain any coatings, additives, surfactants or preservatives.

For product inquiries and technical support please contact LumiraDx Technical Support.

US

Email: customerservices.US@lumiradx.com

Telephone: 1-888-586-4721

www.lumiradx.com

International

Email: customerservices@lumiradx.com

Telephone: +44 (0)1172841222

www.lumiradx.com

Supplemental Instructions

Transfer Pipette Configuration

20µL Dual-Bulb Plastic Transfer Pipettes (single use)

Squeeze the upper bulb to draw up 20µl of QC material into the pipette.

Hold the pipette over the sample application area of the Test Strip and squeeze the upper bulb for a second time to dispense 20µL of QC material on to the Test Strip.

Note: the tip of the pipette will be tapered.

20µL Single-Bulb Plastic Transfer Pipettes (single use)

Squeeze the bulb, drawing up QC material to where the tip of the pipette tapers as indicated by the arrow on the diagram. Take care to fill only the tip of the pipette to collect approximately 20µL of QC material.

Ensure no air bubbles are present within the pipette tip and that the whole tip of the pipette is filled with QC material.

Hold the pipette over the sample application area of the Test Strip and squeeze the bulb for a second time to dispense 20µL of QC material on to the Test Strip.

Note: The Platform will audibly confirm that sample is detected and prompt the user to close the door.

Calibrated Laboratory Pipette (set to 20µL, with appropriate tips)

Follow the applicable manufacturer's recommendations for correctly dispensing exactly 20µL of QC material to the Test Strip.

Manufacturing and Distribution Information

Manufactured by:

LumiraDx UK Ltd

Dumyat Business Park

Alloa

FK10 2PB, UK

Registration Number: 09206123

Authorized representative in the European Union:

LumiraDx AB

Västra Vägen 5A

16961 Solna, Sweden

US Office:

LumiraDx

221 Crescent Street

Suite 502

Waltham

Massachusetts 02453

USA

Copyright © 2021 LumiraDx UK LTD. All rights reserved worldwide. LumiraDx and Flame logo are trademarks of LumiraDx International LTD. Full details of these and other registrations of LumiraDx can be found at lumiradx.com/IP. All other trademarks are the property of their respective owners. Content should be used for the use of the LumiraDx products only and in line with instructions provided. You may not, except with our express written permission, distribute or commercially exploit the content. Nor may you transmit it or store it in any other form of electronic retrieval system other than for the purpose of use of the LumiraDx Instrument or LumiraDx Test Strips. Information provided is subject to change without notice.

Product is not available in all countries and regions. Please check with your local LumiraDx sales representative or distributor for availability in specific markets. Available in the USA under FDA Emergency Use Authorization.

In the USA, this test has not been FDA cleared or approved; this test has been authorized by FDA under an EUA for use by authorized laboratories; use by laboratories certified under the CLIA, 42 U.S.C. §263a, that meet requirements to perform moderate, high or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. This test has been authorized only for the detection of proteins from SARS-CoV-2, not for for any other viruses or pathogens. In the USA, this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of the virus that causes COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

OS-04284-01 APPROVED FOR USE IN THE US. EMERGENCY USE AUTHORIZED ONLY. S-COM-ART-00195 R4 Date of Rev 2021/05

Models: SARS-CoV-2 Ag QC Transfer Pipettes, SARS-CoV-2 Ag QC, Transfer Pipettes, Pipettes

File Info : application/pdf, 1 Pages, 305.44KB

PDF preview unavailable. Download the PDF instead.

lumiradx-sars-cov-2-ag-technical-bulletin-–-qc-transfer-pipettes-ivd-eua-r4

References

Adobe Illustrator 25.2 (Windows) Adobe PDF library 15.00

Related Documents

Preview LumiraDx Platform User Manual: Comprehensive Guide
This user manual provides detailed instructions for operating and maintaining the LumiraDx Platform, a point-of-care system for in vitro diagnostic tests. Learn about setup, testing procedures, troubleshooting, and safety information.
Preview LumiraDx Instrument Cleaning and Disinfection Procedure
This technical bulletin outlines the proper cleaning and disinfection procedures for the LumiraDx Instrument, including guidance for blood-based and swab-based samples, and recommended disinfectant materials.
Preview LumiraDx SARS-CoV-2 Ag Quality Controls Instructions
Instructions for the LumiraDx SARS-CoV-2 Ag Quality Controls, including intended use, procedure, symbols glossary, customer service information, and limited warranty.
Preview LumiraDx SARS-CoV-2 Ag Test Specifications and Performance
Detailed specifications and clinical performance data for the LumiraDx SARS-CoV-2 Ag Test, an in vitro diagnostic test for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigens.
Preview Optimizing Your LumiraDx Sample Application Process
This technical bulletin provides guidance on optimizing the sample application process for the LumiraDx Test Strip, ensuring accurate and efficient results. It covers sample application, detection, and removal procedures, along with troubleshooting common issues.
Preview LumiraDx Platform Returns: A Comprehensive Guide
This document provides detailed instructions and guidance for returning the LumiraDx Platform, including procedures for data handling, disinfection, packaging, and shipping. It ensures proper return of instruments and associated materials for investigation and quality control purposes.
Preview LumiraDx SARS-CoV-2 Ag Test: Quick Reference Instructions
Concise guide for performing the LumiraDx SARS-CoV-2 Ag Test, including sample preparation, running the test on the LumiraDx Platform, and interpreting results. For Emergency Use Authorization (EUA) only.
Preview LumiraDx SARS-CoV-2 Ag Test Fact Sheet for Healthcare Providers
This fact sheet provides information on the LumiraDx SARS-CoV-2 Ag Test, including its intended use, interpretation of results, and emergency use authorization by the FDA.